Leveraging murine models of the neurofibromatosis type 1 cancer predisposition syndrome to elucidate the cellular circuits that drive pediatric low-grade glioma formation and progression

Authors

David H Gutmann, Washington University School of Medicine in St. Louis

Journal

Neuro-Oncology Advances

Publication Date

1-1-2024

Volume

6

Issue

1

First Page

vdae054

Document Type

Open Access Publication

DOI

10.1093/noajnl/vdae054

Rights and Permissions

David H Gutmann, Leveraging murine models of the neurofibromatosis type 1 cancer predisposition syndrome to elucidate the cellular circuits that drive pediatric low-grade glioma formation and progression, Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae054, https://doi.org/10.1093/noajnl/vdae054. https://academic.oup.com/noa/article/6/1/vdae054/7687612?login=true. © The Author(s) 2024. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Gutmann, David H, "Leveraging murine models of the neurofibromatosis type 1 cancer predisposition syndrome to elucidate the cellular circuits that drive pediatric low-grade glioma formation and progression." Neuro-Oncology Advances. 6, 1. vdae054 (2024).
https://digitalcommons.wustl.edu/oa_4/3878

Department

ICTS (Institute of Clinical and Translational Sciences)